Search results
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 2 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 2 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread ...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 15 hours agoThe patient developed severe gastrointestinal symptoms four months after receiving CAR T-cell...
City of Hope Receives Grants For Stem Cell Lab
Los Angeles Business Journal· 4 days agoDuarte-based City of Hope has been awarded more than $11 million in grants from California’s stem cell institute in recent weeks.
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 17 hours agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
New Scientist· 1 day agoA CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for...
New findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
Medical Xpress· 3 days agoCurrently, the CD55 protein is difficult to target because of its protective role in the immune...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 7 days agoROCK HILL, S.C. - Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from...
POEMS Syndrome
Health via Yahoo News· 7 days agoPOEMS is an acronym for the disorder's five common symptom types: polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 1 day agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...